The European Interbalkan Medical Center, is a major private general hospital located and based in Thessaloniki, Greece, on the road to the airport, opposite of the commercial center of Apollonia and close to Mediterranean Cosmos. It was founded by businessman Giorgos Apostolopoulos in 2000.

There are 383 beds in Interbalkan European Medical Center.

During the past decade, Interbalkan European Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Interbalkan European Medical Center" are "Acute Heart Failure With Reduced Ejection Fraction" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Interbalkan European Medical Center" in a lesser frequency.

Most popular intervention types in "Interbalkan European Medical Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "APD418" (1 trials), "Herceptin®" (1 trials), "PF-05280014" (1 trials), "Paclitaxel" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Interbalkan European Medical Center" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Interbalkan European Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Interbalkan European Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Interbalkan European Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".